Okomera

2 known investors

Okomera builds a platform combining miniaturized tumor-on-chip technology and AI imaging to analyze patient-derived biopsies and predict personalized drug response for cancer treatment. Its tools serve clinicians and drug developers, spanning drug development to clinical decision-making.

AI & Machine LearningBiotechDigital Health